Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Cho YK, Kim YJ, Jung CH
Among ZEPBOUND-treated patients, hypersensitivity reactions were more frequent in those with anti-tirzepatide antibodies (6.2%) compared to those who did not develop anti-tirzepatide antibodies (3%) [see Clinical Pharmacology (12.6)]
Methods A total of 165 subjects were randomized to metformin and sitagliptin (Met+Sita, n =65), metformin, sitagliptin, and acarbose (Met+Sita+Acarb, n =66) and sitagliptin and acarbose (Sita+Acarb, exploratory assessment, n =34) therapy in five institutions in Korea
This is especially useful where between-person confounding is high
US$ 25.41
US$ 29.52
US$ 26.48
